title: Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer.
abstract: OBJECTIVE
  This study was conducted to determine whether overexpression of the p53 tumor suppressor gene is associated with poor outcome in early-stage endometrial cancers and whether a racial difference in the frequency of p53 overexpression contributes to the observed racial disparity in survival rates.
  
  
  METHODS
  Immunostaining for the p53 gene was performed in 164 women with stage I endometrial adenocarcinomas.
  
  
  RESULTS
  Overexpression of mutant p53 protein was seen in 28 out of 164 (17%) cases and was associated with a poor histologic grade (p = 0.003) and a nonendometrioid histologic appearance (p = 0.06). Overexpression also was three times more frequent in blacks (15 out of 44, 34%) than in whites (13 out of 117, 11%) (p = 0.003). Recurrent disease developed in 15 out of 164 (9%) cases and was more than twice as frequent in cases when the p53 gene was overexpressed (5 out of 28, 18%) than in cases with normal expression (10 out of 136, 7%). Recurrent disease was seen in 6 out of 44 (14%) blacks compared to 9 out of 117 (8%) whites.
  
  
  CONCLUSIONS
  These data support the hypothesis that differences in the frequency of alteration of the p53 tumor suppressor gene contribute to the racial disparity in endometrial cancer survival.
authors.affiliation: Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Clifford
authors.forename: C P
authors.initials: CP
authors.lastname: Kaminetsky
authors.forename: F D
authors.initials: FD
authors.lastname: Cirisano
authors.forename: R
authors.initials: R
authors.lastname: Dodge
authors.forename: J T
authors.initials: JT
authors.lastname: Soper
authors.forename: D L
authors.initials: DL
authors.lastname: Clarke-Pearson
authors.forename: A
authors.initials: A
authors.lastname: Berchuck
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D000328:Adult; D044383:Black People / Q000235:genetics*; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics; D044465:White People / Q000235:genetics*
chemical_list: D016159:Tumor Suppressor Protein p53